Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma.
about
Tissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaCirculating tumor DNA in hepatocellular carcinoma: trends and challengesRole of epigenetic aberrations in the development and progression of human hepatocellular carcinomaGlobal methylation, oxidative stress, and relative telomere length in biliary atresia patientsOutlook on Thailand's genomics and computational biology research and development.Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instabilityDNA methylation: potential biomarker in Hepatocellular Carcinoma.Methylation Levels of LINE-1 As a Useful Marker for Venous Invasion in Both FFPE and Frozen Tumor Tissues of Gastric CancerHypomethylation of intragenic LINE-1 represses transcription in cancer cells through AGO2.Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma.Decline in genomic DNA methylation through aging in a cohort of elderly subjectsLINE-1 hypomethylation in blood and tissue samples as an epigenetic marker for cancer risk: a systematic review and meta-analysis.Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencingPatterns and possible roles of LINE-1 methylation changes in smoke-exposed epithelia.Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma.Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.LINE-1 and Alu hypomethylation in mucoepidermoid carcinoma.Expression of a LINE-1 endonuclease variant in gastric cancer: its association with clinicopathological parameters.Dietary alleviation of maternal obesity and diabetes: increased resistance to diet-induced obesity transcriptional and epigenetic signatures.Direct quantification of cell-free, circulating DNA from unpurified plasmaDNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinomaLong interspersed nuclear element-1 hypomethylation in cancer: biology and clinical applications.Prenatal synthetic glucocorticoid treatment changes DNA methylation states in male organ systems: multigenerational effects.The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers.Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.LINE-1 methylation patterns of different loci in normal and cancerous cellsRepetitive element hypomethylation in blood leukocyte DNA and cancer incidence, prevalence, and mortality in elderly individuals: the Normative Aging Study.The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients.DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiologyPrognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer.Hypomethylation of repeated DNA sequences in cancer.DNA methylation and cancer development: molecular mechanism.Cell-free DNA for the detection of pancreatic, liver and upper gastrointestinal cancers: has progress been made?Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV-associated neoplasms.Prospective changes in global DNA methylation and cancer incidence and mortality.Current and Emerging Technologies for the Analysis of the Genome-Wide and Locus-Specific DNA Methylation Patterns.Distinctive patterns of age-dependent hypomethylation in interspersed repetitive sequences.Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma.
P2860
Q26743361-9664B20E-545F-45F3-9138-B83282D289AAQ26749417-3FE6BA08-A9B1-4F7E-A12F-B8E4EACF78E8Q27023524-17C812B8-3579-40DE-BC82-ADE63276E308Q28395565-B00E05BE-5E95-4EC5-AEBE-C425EEBECE4EQ30397955-2DB02007-7B45-4DE6-86EF-D957CC447CC7Q33419085-F80FC8A2-A20A-467F-B5FC-871A9E0F436CQ33617129-E5A95DCB-C281-47B2-84E5-4B4439ED9921Q33775120-C704F018-6F9C-4424-AA99-77845AACF231Q33851380-F7A273AA-1A8C-481A-842C-83360C89B465Q34168643-B1B12710-2D3B-41E7-A955-44C5A19FA6E2Q34206283-E315A4F8-16BA-4C00-B026-62A6EBCD87D9Q34282505-79318FD0-E4A7-43C7-AE79-3AB618F0CFFCQ34382581-FF85EE34-0B24-4AB3-91CB-A4BC1FA39FA2Q34428641-4DBE01EA-1260-4681-84BF-3AA298B33C56Q34548742-94B61715-A35A-42EC-BF2C-3A8E1888A649Q34598189-0BF920DE-0CD6-450A-8AAF-683E4C292B4BQ34627497-5E19C993-9674-4389-9C90-37944D7DE803Q34746787-9C9D1D77-12B2-44EA-A4DC-FC79EAC07B91Q34796061-53D9A260-7842-4A91-A618-900C2A1CE559Q35111355-A2B20A5B-6AE0-4BB1-B6B5-9294E6B6041BQ35197356-66469CBE-0CFE-4271-B0D7-6213E227E12CQ35301805-BBEEB73B-A81A-474B-8833-F81C9A61BC04Q36001900-4742CB97-95B4-4260-952A-C982F8B4D366Q36174008-CC16F073-CE7A-4497-BB6E-47D0B711C167Q36217905-E09DAC02-9B64-47E9-99C1-C7949BEA2A43Q36715039-B222E230-DB0F-4161-9A42-39A7BF009AFCQ36909281-E610B419-48BF-4AFD-BF03-C21C0BA671C5Q37119615-37001FEB-15F2-41AB-B31D-0C7C5F8538D8Q37225239-C98E75B0-408C-422C-978E-4ABBAB6F700EQ37234443-8D968C41-3799-4866-A5F5-02270AF40D42Q37263149-885C1410-936D-4014-AF24-E452E6A8C911Q37960201-06CAD17F-8DF6-4BC4-A76B-37B6EA48D7BCQ37961724-13B57EEE-AE69-4C8F-A81F-DCD8FAB42159Q38091024-F5A71ABF-1507-41E6-BD23-4065D69DE218Q38167884-90E55CFC-87B3-4D7E-9E92-072686017B80Q38643087-85E13D9D-D61E-41AF-B117-420D7F94B644Q38847714-52A947B5-DA5D-444C-9E9E-DF1FEC0AF05FQ39003554-4F0F4A9B-BABC-4C1B-8202-1C646D803635Q39107766-3731F571-080B-4878-977A-D971E85F842CQ39372582-40ED572F-701D-49CE-8CC1-B5D79FD09C82
P2860
Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Serum LINE-1 hypomethylation a ...... for hepatocellular carcinoma.
@en
Serum LINE-1 hypomethylation a ...... for hepatocellular carcinoma.
@nl
type
label
Serum LINE-1 hypomethylation a ...... for hepatocellular carcinoma.
@en
Serum LINE-1 hypomethylation a ...... for hepatocellular carcinoma.
@nl
prefLabel
Serum LINE-1 hypomethylation a ...... for hepatocellular carcinoma.
@en
Serum LINE-1 hypomethylation a ...... for hepatocellular carcinoma.
@nl
P2093
P1433
P1476
Serum LINE-1 hypomethylation a ...... for hepatocellular carcinoma.
@en
P2093
Apiwat Mutirangura
Naruemon Wisedopas
Nusara Hourpai
Pisit Tangkijvanich
Prakasit Rattanatanyong
Varocha Mahachai
P304
P356
10.1016/J.CCA.2006.12.029
P577
2007-01-19T00:00:00Z